|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 106, 709-717, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
HD Schulte, WH Bircks, B Loesse, EA Godehardt and B Schwartzkopff
A complete clinical study was performed for 364 patients with hypertrophic
obstructive cardiomyopathy who were operated on in the years 1963 to 1991
(217 male, 146 female, mean age 40 years, range 5 months to 76 years).
Transaortic subvalvular myectomy was performed in 272 patients (hospital
mortality 2.9%), and 92 patients needed additional cardiac procedures
simultaneously (hospital mortality 10.9%). A complete follow-up study
(100%) included 346 patients who survived the operation. The shortest
follow-up time was 2 months and the longest 25.2 years (mean 8.2 years).
Most of the patients improved clinically by one to three classes (New York
Heart Association). During the observation period 38 patients (10.4%) died.
The death of 17 patients was closely related to the original disease
(4.9%). Other causes, unrelated to hypertrophic obstructive cardiomyopathy,
were responsible for the death of 21 patients (5.8%). In consideration of
these data, the yearly total death rate was 2.2%; in close relation to
hypertrophic obstructive cardiomyopathy it was about 0.6%. The cumulative
survivals were 88% after 10 years and 72% after 20 years. In our long-term
clinical experience it is increasingly evident, despite the restrictions of
a retrospective study, that patients with symptomatic hypertrophic
obstructive cardiomyopathy and failing medical therapy benefit from
transthoracic subvalvular myectomy.
ARTICLES
Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years
University Hospital Heart Center, Heinrich Heine-University Hospital, Dusseldorf, Germany.
This article has been cited by other articles:
![]() |
V. L. Fernandes, C. Nielsen, S. F. Nagueh, A. E. Herrin, C. Slifka, J. Franklin, and W. H. Spencer III Follow-Up of Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy: The Baylor and Medical University of South Carolina Experience 1996 to 2007 J. Am. Coll. Cardiol. Intv., October 1, 2008; 1(5): 561 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Fifer and G. J. Vlahakes Management of Symptoms in Hypertrophic Cardiomyopathy Circulation, January 22, 2008; 117(3): 429 - 439. [Full Text] [PDF] |
||||
![]() |
M. A. Fifer Most Fully Informed Patients Choose Septal Ablation Over Septal Myectomy Circulation, July 10, 2007; 116(2): 207 - 216. [Full Text] [PDF] |
||||
![]() |
A. Ralph-Edwards, A. Woo, B. W. McCrindle, J. L. Shapero, L. Schwartz, H. Rakowski, E. D. Wigle, and W. G. Williams Hypertrophic obstructive cardiomyopathy: Comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 351 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron, J. A. Dearani, S. R. Ommen, M. S. Maron, H. V. Schaff, B. J. Gersh, and R. A. Nishimura The case for surgery in obstructive hypertrophic cardiomyopathy J. Am. Coll. Cardiol., November 16, 2004; 44(10): 2044 - 2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. van Dockum, F. J. ten Cate, J. M. ten Berg, A. M. Beek, J. W. R. Twisk, J. Vos, M. B. M. Hofman, C. A. Visser, and A. C. van Rossum Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging J. Am. Coll. Cardiol., January 7, 2004; 43(1): 27 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Sherrid, F. A. Chaudhry, and D. G. Swistel Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction Ann. Thorac. Surg., February 1, 2003; 75(2): 620 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Minami, D. Boethig, H. Woltersdorf, D. Seifert, and R. Korfer Long term follow-up of surgical treatment of hypertrophic obstructive cardiomyopathy (HOCM): the role of concomitant cardiac procedures Eur. J. Cardiothorac. Surg., August 1, 2002; 22(2): 206 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Gietzen, C. J. Leuner, L. Obergassel, C. Strunk-Mueller, and H. Kuhn Role of Transcoronary Ablation of Septal Hypertrophy in Patients With Hypertrophic Cardiomyopathy, New York Heart Association Functional Class III or IV, and Outflow Obstruction Only Under Provocable Conditions Circulation, July 23, 2002; 106(4): 454 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ritter, S. Hack, K. Schuh, N. Rothlein, A. Perrot, K. J. Osterziel, H. D. Schulte, and L. Neyses Calcineurin in Human Heart Hypertrophy Circulation, May 14, 2002; 105(19): 2265 - 2269. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron Hypertrophic Cardiomyopathy: A Systematic Review JAMA, March 13, 2002; 287(10): 1308 - 1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Wigle, L. Schwartz, A. Woo, and H. Rakowski To ablate or operate? that is the question! J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1707 - 1710. [Full Text] [PDF] |
||||
![]() |
W. H. Merrill, G. C. Friesinger, T. P. Graham Jr, B. F. Byrd III, D. C. Drinkwater Jr, K. G. Christian, and H. W. Bender Jr Long-lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy Ann. Thorac. Surg., June 1, 2000; 69(6): 1732 - 1735. [Abstract] [Full Text] [PDF] |
||||
![]() |
W Ruzyllo, L Chojnowska, M Demkow, A Witkowski, B Kusmierczyk-Droszcz, W Piotrowski, L Rausinska, M Karcz, L Malecka, and W Rydlewska-Sadowska Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy Eur. Heart J., May 1, 2000; 21(9): 770 - 777. [Abstract] [PDF] |
||||
![]() |
S. R. Ommen, R. A. Nishimura, R. W. Squires, H. V. Schaff, G. K. Danielson, and A. J. Tajik Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: A comparison of objective hemodynamic and exercise end points J. Am. Coll. Cardiol., July 1, 1999; 34(1): 191 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron, R. A. Nishimura, W. J. McKenna, H. Rakowski, M. E. Josephson, and R. S. Kieval Assessment of Permanent Dual-Chamber Pacing as a Treatment for Drug-Refractory Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy : A Randomized, Double-Blind, Crossover Study (M-PATHY) Circulation, June 8, 1999; 99(22): 2927 - 2933. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Kazmierczak, Z Kornacewicz-Jach, M Kisly, R Gil, and A Wojtarowicz Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy Heart, September 1, 1998; 80(3): 257 - 262. [Abstract] [Full Text] |
||||
![]() |
M. H. Schonbeck, H. P. Brunner-La Rocca, P. R. Vogt, M. L. Lachat, R. Jenni, O. M. Hess, and M. I. Turina Long-Term Follow-up in Hypertrophic Obstructive Cardiomyopathy After Septal Myectomy Ann. Thorac. Surg., May 1, 1998; 65(5): 1207 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Gol, M. Emir, T. Keles, S. A. Kucuker, C. L. Birincioglu, Y. H. Karagoz, T. Kural, O. Tasdemir, S. Goksel, and K. Bayazit Septal Myectomy in Hypertrophic Obstructive Cardiomyopathy: Late Results With Stress Echocardiography Ann. Thorac. Surg., September 1, 1997; 64(3): 739 - 745. [Abstract] [Full Text] |
||||
![]() |
P. Spirito, C. E. Seidman, W. J. McKenna, and B. J. Maron The Management of Hypertrophic Cardiomyopathy N. Engl. J. Med., March 13, 1997; 336(11): 775 - 785. [Full Text] [PDF] |
||||
![]() |
D. A. Theodoro, G. K. Danielson, R. H. Feldt, and B. J. Anderson HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY IN PEDIATRIC PATIENTS: RESULTS OF SURGICAL TREATMENT J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1589 - 1599. [Abstract] [Full Text] |
||||
![]() |
R. B. McCully, R. A. Nishimura, A. J. Tajik, H. V. Schaff, and G. K. Danielson Extent of Clinical Improvement After Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy Circulation, August 1, 1996; 94(3): 467 - 471. [Abstract] [Full Text] |
||||
![]() |
R. C. Robbins and E. B. Stinson LONG-TERM RESULTS OF LEFT VENTRICULAR MYOTOMY AND MYECTOMY FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY J. Thorac. Cardiovasc. Surg., March 1, 1996; 111(3): 586 - 594. [Abstract] [Full Text] |
||||
![]() |
B. Heric, B. W. Lytle, D. P. Miller, E. R. Rosenkranz, H. M. Lever, and D. M. Cosgrove Surgical management of hypertrophic obstructive cardiomyopathy:Early and late results J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 195 - 208. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |